On Jun. 30, 2022, Pfizer and BioNTech announced a vaccine supply agreement with the U.S. government to support the continued fight against COVID-19. Under the agreement, the U.S. government received 105 million doses (30 ﾵg, 10 ﾵg and 3 ﾵg).

This may include adult Omicron-adapted COVID-19 vaccines, subject to authorization from the U.S. Food and Drug Administration (FDA). The doses were planned to be delivered in the late summer 2022.